Schedule III Supplementary Insurance Information

12 Months Ended

Dec. 31, 2015

Supplementary Insurance Information

											Schedule III

At December 31, 2015 and 2014

								Liability
								for Unpaid
								Losses and
								Loss
						Deferred		Adjustment				Policy
						Policy		Expenses,				and
						Acquisition		Future Policy		Unearned		Contract
Segment (in millions)						Costs		Benefits		Premiums		Claims
2015
Non-Life Insurance Companies					$	2,631	$	69,213	$	20,961	$	-
Life Insurance Companies						8,467		42,893		-		851
Corporate and Other^(a)						17		6,421		357		11
					$	11,115	$	118,527	$	21,318	$	862
2014
Non-Life Insurance Companies					$	2,551	$	77,839	$	21,325	$	-
Life Insurance Companies						7,258		42,004		-		818
Corporate and Other^(a)						18		166		(1)		11
					$	9,827	$	120,009	$	21,324	$	829


For the years ended December 31, 2015, 2014 and 2013

						Losses		Amortization
		Premiums				and Loss		of Deferred
		and		Net		Expenses		Policy		Other		Net
		Policy		Investment		Incurred,		Acquisition		Operating		Premiums
Segment (in millions)		Fees		Income		Benefits		Costs		Expenses		Written^(b)
2015
Commercial Insurance	$	22,720	$	5,474	$	20,425	$	2,342	$	3,775	$	21,486
Consumer Insurance		16,642		8,322		13,791		2,887		7,013		11,580
Corporate and Other^(a)		48		257		860		7		-		-
	$	39,410	$	14,053	$	35,076	$	5,236	$	10,788	$	33,066
2014
Commercial Insurance	$	22,408	$	6,393	$	16,985	$	2,512	$	3,794	$	22,044
Consumer Insurance		17,389		9,082		14,149		2,759		7,087		12,412
Corporate and Other^(a)		72		604		915		59		6		-
	$	39,869	$	16,079	$	32,049	$	5,330	$	10,887	$	34,456
2013
Commercial Insurance	$	22,209	$	6,653	$	17,415	$	2,418	$	4,049	$	21,928
Consumer Insurance		17,554		9,352		14,434		2,836		6,826		12,700
Corporate and Other^(a)		76		(195)		1,546		(97)		8		-
	$	39,839	$	15,810	$	33,395	$	5,157	$	10,883	$	34,628

(a) Includes consolidation and elimination entries.

(b) Balances reflect the segment changes discussed in Note 3 – Segment Information to the Consolidated Financial Statements.